Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Woodcock To Be Acting US FDA Commissioner; Sharfstein Tops Biden's List Of Candidates For Post

Jan 15 2021

• By Sarah Karlin-Smith

Related Content

FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit

Jan 17 2011

US FDA Faces Succession Questions As Hahn’s Departure Nears

Jan 06 2021

Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue

Nov 24 2020

COVID-19 Staff Shakeup: Woodcock Moves to Commissioner's Office As Marks Drops Out Of 'Warp'

May 23 2020

A Return Trip For Kessler At US FDA? It Wouldn’t Be The First Time It’s Happened

Dec 03 2020

Plasma Authorization Raises Fears Of Politically-Influenced COVID-19 Vaccine Decisions, Compromised FDA

Aug 25 2020

Sharfstein: US FDA Incentives Not Broke, But Fix Them

Jan 15 2020

OTC Regulatory Pathway Needs NDA Flexibility, Monograph Scope – Sharfstein

Jul 30 2015

Congress Should Open CBD Door, Close VMS Market Holes – Sharfstein, Cohen

Jun 14 2019

Additional Topics

International United States Executive Changes FDA Politics Enforcement Leadership Manufacturing Policy Regulation Consumer

More from Leadership

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window